Abrams’ biopsy is not recommended by the British Thoracic Society statement (British Thoracic Society Standards of Care Committee. Statement on malignant mesothelioma in the UK. Thorax 2007; 62:1–19. November 2007) on mesothelioma. Our department performs Abrams’ pleural biopsy when investigating patients with pleural effusion and suspected mesothelioma. We have audited our use of these investigations.
Patient records were searched over the last seven years. On 80 occasions a diagnosis of mesothelioma was made. The ages ranged from 46 to 93 (mean 71). The male to female ratio was 7:1.
Tissue diagnosis was achieved as follows: diagnostic pleural biopsy 35 (44%), CT  and ultrasound  -guided biopsy 14 (17.5%), thoracoscopy 21 (26%), open lung biopsy 3 (4%), and at post-mortem 7 (9%). There were no significant side-effects from our pleural procedures.
We believe our practice reduces the frequency of the need for CT-guided biopsies.
Abram's pleural biopsy provides our patients with a safe prompt investigation that reduces their exposure to radiation.
Jasdeep Khangura, No Financial Disclosure Information; No Product/Research Disclosure Information